Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 20.10 Delayed Data As of Sep 29 |  -0.13 / -0.64%Today’s Change | 18.84 Today|||52-Week Range 33.49 | -32.09% Year-to-Date |
Latest BCYC News | Press Releases
No recent news for Bicycle Therapeutics PLC.
Today’s Trading
| Previous close | 20.23 |
| Today’s open | 20.18 |
| Day’s range | 19.85 - 20.29 |
| Volume | 6,071 |
| Average volume (3 months) | 272,346 |
| Market cap | $833.0M |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -42.46% |
| Earnings growth (this year) | -38.01% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +23.59% |
| P/E ratio | NM |
| Price/Sales | 60.74 |
| Price/Book | 2.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| COGTCogent Biosciences I... | -0.06 | -0.61% |
| ADMAADMA Biologics Inc | +0.04 | +1.13% |
| ---- | ||
| MORMorphoSys AG | -0.06 | -0.88% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | -$1.35 |
| Annual revenue (last year) | $14.5M |
| Annual profit (last year) | -$112.6M |
| Net profit margin | -779.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
